Information to the Marketing Authorisation Holder - Nasonex
Referral Art. 30, EMEA/H/A-30/1375 regarding Nasonex and associated names was finalised 20 January 2015.
Information regarding referral
The applicant shall apply for this change either as IA(IN) C.I.1.a. (using the proposed Icelandic text unchanged) or IB.C.I.1.a. (if the proposed Icelandic text must be changed to adapt to the relevant text).